Clorox is moving higher after regulatory and execution uncertainty around its biggest recent strategic move faded: an SEC Form 8-K confirms Clorox completed its previously announced purchase of GOJO Industries, the maker of Purell, on April 1, 2026. With the deal now closed, the market is shifting from “will it happen?” risk to “how well will it integrate?” upside, helping lift the stock.

The acquisition adds a scaled hygiene platform anchored by Purell and provides Clorox more exposure to professional and institutional end-markets alongside its core consumer staples portfolio. Confirmation of closing is often a catalyst for staples stocks because it removes a major overhang (timing, approvals, and financing questions) and allows investors to underwrite synergy delivery and operational execution on a firmer timeline.

Key near-term swing factors include integration execution (especially supply chain, salesforce, and back-office alignment), any commentary on leverage and capital allocation, and whether Clorox updates fiscal-year expectations to reflect the business combination now that it is finalized. Investors will also be focused on evidence that the acquired hygiene franchise can support steadier volume trends and margins as Clorox continues broader operational initiatives.